Details for New Drug Application (NDA): 089410
✉ Email this page to a colleague
The generic ingredient in POLOCAINE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 089410
Tradename: | POLOCAINE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | mepivacaine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 089410
Physiological Effect | Local Anesthesia |
Medical Subject Heading (MeSH) Categories for 089410
Suppliers and Packaging for NDA: 089410
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
POLOCAINE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 089410 | ANDA | A-S Medication Solutions | 50090-4408 | 50090-4408-0 | 1 VIAL, MULTI-DOSE in 1 BAG (50090-4408-0) / 50 mL in 1 VIAL, MULTI-DOSE |
POLOCAINE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 089410 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1535 | 51662-1535-3 | 21 POUCH in 1 BOX (51662-1535-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1535-2) / 50 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2% | ||||
Approval Date: | Dec 1, 1986 | TE: | AP | RLD: | No |
Complete Access Available with Subscription